Medium NAPLEX Bioavailability Practice Questions
Medium NAPLEX Bioavailability Practice Questions
Mastering pharmacokinetic calculations is essential for success on the North American Pharmacist Licensure Examination, and understanding bioavailability is a cornerstone of this competency. This guide provides detailed Medium NAPLEX Bioavailability Practice Questions to help you refine your skills in determining drug absorption and dosage adjustments.
Concept Explanation
Bioavailability () is the fraction of an administered dose of unchanged drug that reaches the systemic circulation. It is a critical pharmacokinetic parameter because it determines the actual amount of drug available to produce a therapeutic effect after extravascular administration, such as oral or subcutaneous routes. For intravenous (IV) administration, bioavailability is considered 100% () because the drug is injected directly into the bloodstream. When comparing different dosage forms or routes, clinicians use the Absolute Bioavailability formula:
Additionally, pharmacists often calculate Relative Bioavailability to compare two different formulations (e.g., tablet vs. capsule) of the same drug. If a patient is being transitioned from an IV to an oral formulation, the dose must often be adjusted based on the bioavailability to maintain the same systemic exposure. This transition is a common focus in NAPLEX Prep, as it ensures patient safety and therapeutic efficacy. Factors such as first-pass metabolism in the liver, drug solubility, and gastric pH can significantly impact the final value of . For more complex clinical scenarios involving organ dysfunction, you may also want to review Medium NAPLEX Liver Disease Practice Questions to see how hepatic impairment alters drug processing.
Solved Examples
Example 1: Calculating Absolute Bioavailability
A new drug was administered to a patient. A 100 mg IV dose resulted in an AUC of 50 mg*hr/L. A 200 mg oral dose of the same drug resulted in an AUC of 40 mg*hr/L. Calculate the absolute bioavailability () of the oral formulation.
- Identify the known values: , , , .
- Apply the formula: .
- Substitute the values: .
- Calculate: .
- The absolute bioavailability is 0.4 or 40%.
Example 2: IV to Oral Dose Conversion
A patient is receiving 500 mg of an antibiotic intravenously every 12 hours. The oral bioavailability of this antibiotic is 0.75. What is the equivalent oral dose to maintain the same systemic exposure?
- Recall the relationship: .
- Substitute the values: .
- Calculate: .
- The pharmacist would likely round this to the nearest available dosage strength, such as 650 mg or 750 mg, depending on clinical judgment and product availability.
Example 3: Relative Bioavailability
A pharmaceutical company is testing a new liquid formulation against their standard 250 mg tablet. The AUC for the 250 mg tablet is 120 mg*hr/L, and the AUC for a 250 mg liquid dose is 150 mg*hr/L. Calculate the relative bioavailability of the liquid compared to the tablet.
- Formula for relative bioavailability: .
- Since the doses are equal (250 mg), the formula simplifies to: .
- Substitute the values: .
- Calculate: .
- The liquid formulation is 125% as bioavailable as the tablet.
Practice Questions
1. A drug has an oral bioavailability of 60%. If a patient requires a systemic dose equivalent to 150 mg IV, what oral dose should be prescribed?
2. Calculate the absolute bioavailability () given the following data: IV Dose = 50 mg, IV AUC = 100 mg*hr/L; Oral Dose = 250 mg, Oral AUC = 300 mg*hr/L.
3. A patient is being switched from a 10 mg IV dose of a medication to an oral liquid formulation. The oral bioavailability of the liquid is 0.25. What is the equivalent oral dose?
Track your NAPLEX progress intelligently.
Use AI-powered analytics to identify weak areas and optimize your pharmacy exam preparation.
Track My Progress4. You are comparing two oral formulations of Drug X. Tablet A (500 mg) produces an AUC of 2000. Tablet B (250 mg) produces an AUC of 1200. What is the relative bioavailability of Tablet B compared to Tablet A?
5. A medication has a high first-pass metabolism, resulting in an oral bioavailability of 15%. If the standard oral dose is 300 mg, what is the equivalent IV dose?
6. A patient is taking 120 mg of an oral drug with . Due to a change in clinical status, they must switch to an IV formulation. What is the equivalent IV dose?
7. Using the AI Exam Simulator can help you practice these timings, but for now, solve this: A drug has an IV AUC of 450 mg*hr/L after a 50 mg dose. The same drug given as a 100 mg oral tablet yields an AUC of 600 mg*hr/L. What is the percentage bioavailability?
8. A drug is known to have a bioavailability of 0.8. If the dose is increased from 100 mg to 200 mg, and the pharmacokinetics are linear, what happens to the value of ?
9. A patient is transitioned from 40 mg IV furosemide to oral furosemide. Assuming the bioavailability of oral furosemide is 50%, what oral dose is equivalent?
10. An investigational drug shows an AUC of 80 mg*hr/L after a 20 mg IV bolus. A 100 mg oral dose results in an AUC of 240 mg*hr/L. Calculate the absolute bioavailability.
Answers & Explanations
- Answer: 250 mg.
Using the formula , we get . - Answer: 0.6 or 60%.
. - Answer: 40 mg.
. This is a common calculation for drugs with significant first-pass effect. - Answer: 1.2 (or 120%).
. - Answer: 45 mg.
. Therefore, . - Answer: 48 mg.
. Therefore, . - Answer: 66.7%.
, or 66.7%. - Answer: It remains the same.
In linear pharmacokinetics, bioavailability () is a constant property of the drug formulation and is independent of the dose. - Answer: 80 mg.
. This represents the standard 1:2 IV to PO ratio for furosemide. Check out Medium NAPLEX Heart Failure Practice Questions for more on diuretics. - Answer: 0.6 or 60%.
.
1. Which route of administration is defined as having a bioavailability of 1.0?
Frequently Asked Questions
What is the difference between absolute and relative bioavailability?
Absolute bioavailability compares the bioavailability of a non-intravenous formulation to the intravenous route, while relative bioavailability compares two different non-intravenous formulations to each other. Absolute bioavailability tells you how much drug gets in compared to the "gold standard" of IV, whereas relative bioavailability is often used to establish bioequivalence between brands.
Why does first-pass metabolism decrease bioavailability?
First-pass metabolism occurs when a drug is metabolized by enzymes in the gut wall or the liver before it ever reaches the systemic circulation. This process reduces the amount of active drug that enters the bloodstream, thereby lowering the bioavailability of oral medications compared to parenteral ones.
How is AUC used in bioavailability calculations?
The Area Under the Curve (AUC) represents the total systemic exposure of a drug over time. By comparing the AUC of an oral dose to the AUC of an IV dose (corrected for dosage amounts), pharmacists can determine the fraction of the drug that successfully entered the circulation.
Can bioavailability be greater than 100%?
Absolute bioavailability cannot exceed 100% because no route can deliver more drug to the systemic circulation than direct intravenous injection. However, relative bioavailability can be greater than 1.0 (or 100%) if the test formulation is absorbed better than the reference formulation.
Does food intake affect drug bioavailability?
Yes, food can significantly alter bioavailability by changing gastric emptying time, altering pH, or physically binding to the drug. Depending on the medication, food might increase absorption (e.g., some lipophilic drugs) or decrease it (e.g., many antibiotics), which is why specific administration instructions are vital. For more on drug-nutrient interactions, see the FDA guide on taking medications.
Track your NAPLEX progress intelligently.
Use AI-powered analytics to identify weak areas and optimize your pharmacy exam preparation.
Track My ProgressTags
Enjoyed this article?
Share it with others who might find it helpful.